A phase I study of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumors.
L. M. McGregor
No relevant relationships to disclose
S. L. Spunt
Research Funding - Sanofi
D. Ward
No relevant relationships to disclose
J. Wu
No relevant relationships to disclose
C. Billups
No relevant relationships to disclose
S. P. Ivy
No relevant relationships to disclose
V. M. Santana
No relevant relationships to disclose
M. Fouladi
No relevant relationships to disclose
W. L. Furman
No relevant relationships to disclose